Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Ventripoint Diagnostics Ltd V.VPT

Sector: Healthcare | Sub-Sector: Medical Instruments & Supplies
Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd Ventripoint Diagnostics Ltd is a medical device company engaged in the development of diagnostic tools that monitor patients with heart disease.
Price: $0.055 | Change: $0.00 | %Change: 0.00%
Volume: 4.4m | Day High/Low: 0.09/0.055 | 52 Week High/Low: 0.10/0.04
View modes: 
0 stars

RE:who paid .09?

09:56:29 V 0.09 0.035 4,000 85 Scotia 7 TD Sec K 09:56:29 V 0.09 0.035 33,000 85 Scotia more
0 stars

who paid .09?

.  rate and reply
0 stars

Good news but market skeptical

Market is not totally convinced yet, due to past performances but hopefully this time Ventripoint will get it done right. Not getting too excited about China as usually it will end not up not more
1 star

This will be huge soon!

With all these good news and with a very good chance of an approval from FDA, the sp of this company is going to .50 before june and then who knows who is going to bid to buy this small more
0 stars


Looks like great things are in store for vpt... can't wait! It's about time!!  rate and reply
0 stars

RE:RE:more good news coming

Banderas: I am not sure what kind of good news Mr Adams is implying. I just hope that this is not just another Realcan kind of deal.  rate and reply
0 stars

RE:more good news coming

banderas76 wrote: according to our ceo....mister adams higher and higher!!! And again I will say... when this news comes, I hope that there will be something more to back it up. We have already more
5 stars

more good news coming

according to our ceo....mister adams higher and higher!!!  rate and reply
0 stars

RE:beauty pullback!

Agreed! I am happy enough that we have flushed out some of the cheap shares. We've been treated to a regular news cycle. Now let's see some more next week to keep this moving forward.  rate and reply
0 stars

RE:RE:RE:Ventripoint Announces Acceptance Notification From US-FDA

Actually, it just means the FDA proofreaders have not detected any errors, and it has been forwarded to the reviewers. Proofreader process is allowed to take up to 2 weeks.  rate and reply
0 stars

beauty pullback!

nice pullback on good news, cheap shares were given just now on pullback, bounce to follow! glta  rate and reply
0 stars

RE:RE:could be a great start....

like I said before....between now and 2 years....sales should be on a decent level...and a market cap of 150 million should be possible certainly bc this is inly the beginning pps of 0.5 should more
0 stars

RE:could be a great start....

Yes banderas very good time ahead.. our product has always had massive potential..  its been a tough slog but hopefully this will be the beginning of our breakout... GLTA  rate and reply
0 stars

could be a great start....

only good things to come......sales/Chinese deal/positive fda  rate and reply
0 stars

RE:RE:Ventripoint Announces Acceptance Notification From US-FDA

A quick turnaround from the FDA with acceptance review simply means VPT has the attention of the FDA. I see this as a welcome from the FDA and a guaranteed approval for complete RV. Things can more
5 stars

RE:Ventripoint Announces Acceptance Notification From US-FDA

Wow...36% jump on 1.7 million shares! That is a strong reaction to news that the FDA has accepted the file for review. ;)  rate and reply
5 stars

RE:Ventripoint Announces Acceptance Notification From US-FDA

again good news....could be an exciting coming quarter with positive news concerning some sales, Chinese deal and fda positive news.....  rate and reply
0 stars

Ventripoint Announces Acceptance Notification From US-FDA

Ventripoint Announces Acceptance Notification From US-FDA of Recent 510(k) Submission     SEATTLE, WASHINGTON--(Marketwired - March 27, 2015) - Ventripoint Diagnostics Ltd. ("Ventripoint" more
0 stars

Fiveniner, you're really....

........doing some very fine digging there sir. Very good indeed! More importantly, thank you for sharing with the board. Perhaps we'll get some movement north with this sp seemingly stuck in * more
5 stars

Upcoming Ventripoint Clinical Trial Study   Purpose Ebstein anomaly is a rare congenital heart disease. It encompasses abnormalities of the more